Regions Hospital is a teaching hospital located in Saint Paul, Minnesota, United States. It is now part of HealthPartners. The hospital is an ACS verified Level I Trauma Center for both children and adults, and was Minnesota's first pediatric level one trauma center.

There are 509 (all private) beds in Regions Hospital.

During the past decade, Regions Hospital conducted 271 clinical trials. In the 10-year time frame, 271 clinical trials started and 184 clinical trials were completed, i.e. on average, 67.9% percent of trials that started reached the finish line to date. In the past 5 years, 117 clinical trials started and 108 clinical trials were completed. i.e. 92.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regions Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 179 trials, followed by "Alliance for Clinical Trials in Oncology" with 45 trials sponsored, "SWOG Cancer Research Network" with 43 trials sponsored, "NRG Oncology" with 26 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regions Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 177 trials as a collaborator, "NRG Oncology" with 39 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 128 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Regions Hospital" are "Recurrent Ovarian Carcinoma" (14 trials), "Ovarian Seromucinous Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (11 trials), "Invasive Breast Carcinoma" (10 trials) and "Recurrent Fallopian Tube Carcinoma" (10 trials). Many other conditions were trialed in "Regions Hospital" in a lesser frequency.

Most popular intervention types in "Regions Hospital" are "Drug" (329 trials), "Other" (236 trials), "Biological" (134 trials), "Procedure" (95 trials) and "Radiation" (68 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (114 trials), "Quality-of-Life Assessment" (100 trials), "Questionnaire Administration" (59 trials), "Paclitaxel" (45 trials) and "Carboplatin" (40 trials). Other intervention names were less common.

The vast majority of trials in "Regions Hospital" are 358 trials for "All" genders, 64 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "Regions Hospital". undefined are not yet recruiting, 100 are recruiting, 154 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 139 completed trials in Regions Hospital, 10 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Regions Hospital, 15 "Phase 1" clinical trials were conducted, 192 "Phase 2" clinical trials and 203 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 30 trials that are defined as “Not Applicable".

Regions Hospital has several departments that took part in Clinical trials: "Regions Hospital Cancer Care Center" - 146 trials, "Health Partners Dental Group" - 13 trials, "TRIA Orthopaedic Center" - 3 trials, "Park Nicollet Heart Center" - 2 trials, "Park Nicollet International Diabetes Center" - 2 trials